Variant report
Variant | nsv982602 |
---|---|
Chromosome Location | chr9:17671844-17676006 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540953077 | chr9:17671851-17671852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561508563 | chr9:17671901-17671902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529103522 | chr9:17671948-17671949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs117155677 | chr9:17671974-17671975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372292730 | chr9:17671975-17671976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs183100599 | chr9:17671990-17671991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187826261 | chr9:17672025-17672026 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189610383 | chr9:17672056-17672057 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182736793 | chr9:17672060-17672061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551118828 | chr9:17672067-17672068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566343062 | chr9:17672068-17672069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187704999 | chr9:17672081-17672082 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs77851301 | chr9:17672083-17672084 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144422828 | chr9:17672089-17672090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535882130 | chr9:17672121-17672122 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557081997 | chr9:17672128-17672129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569294333 | chr9:17672154-17672155 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539955305 | chr9:17672168-17672169 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs558357999 | chr9:17672191-17672192 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112706466 | chr9:17672204-17672205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148404142 | chr9:17672208-17672209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs556067236 | chr9:17672212-17672213 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573551953 | chr9:17672226-17672227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192889352 | chr9:17672239-17672240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs961372 | chr9:17672277-17672278 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs184949998 | chr9:17672281-17672282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188475155 | chr9:17672283-17672284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs192188868 | chr9:17672321-17672322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566032555 | chr9:17672346-17672347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548996372 | chr9:17672401-17672402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572069155 | chr9:17672502-17672503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs3780236 | chr9:17672517-17672518 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs550919560 | chr9:17672518-17672519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367889095 | chr9:17672524-17672525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184769763 | chr9:17672525-17672526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371726958 | chr9:17672596-17672597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558321414 | chr9:17672630-17672631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567062932 | chr9:17672632-17672633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555911353 | chr9:17672635-17672636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs189545922 | chr9:17672639-17672640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs555684167 | chr9:17672651-17672652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs4327940 | chr9:17672658-17672659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs201901053 | chr9:17672696-17672697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182035234 | chr9:17672707-17672708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs556093672 | chr9:17672713-17672714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577246163 | chr9:17672720-17672721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142456752 | chr9:17672731-17672732 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557954212 | chr9:17672765-17672766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112241154 | chr9:17672781-17672782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571904699 | chr9:17672808-17672809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 21364760 | CNVD |
Cancer | 22183965 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Thoracic aortic aneurysm | 21698135 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:17668000-17672200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr9:17672000-17673200 | Enhancers | Fetal Brain Male | brain |
3 | chr9:17672200-17672600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
4 | chr9:17673600-17674200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr9:17673600-17674200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
6 | chr9:17673800-17674200 | Enhancers | HUES6 Cell Line | embryonic stem cell |